Drug
Mcla 129
Mcla 129: highest development phase Phase 1/2, developed by Merus. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Merus
Trials
| Drug | Phase | Indication |
|---|---|---|
| MCLA-129 NCT04868877 | Phase 1/2 | Non-Small Cell Lung Cancer Metastatic |
Latest
No recent events.
Follow Mcla 129 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.